Traitements adjuvants du choc septique. «Que reste-t-il de nos amours?»

  • Carlet J
  • 2

    Readers

    Mendeley users who have this article in their library.
  • 0

    Citations

    Citations of this article.

Abstract

Twenty years ago, people thought that mortality of septic shock could be dramatically reduced by compounds like anti-endotoxin and anti-cytokin antibodies. Numerous studies failed to demonstrate any effect and a long period of depression happened. We are probably entering a new therapeutic area with several positive results, including stress doses of corticosteroïds and activated protein C. However the reduction in mortality will be far smaller than anticipated mainly because attribuable mortality of septic shock is more limited than previously thought. © 2002 Éditions scientifiques et médicales Elsevier SAS.

Author-supplied keywords

  • Coagulation
  • Immunological therapy
  • Inflammation
  • Septic shock

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free